Loading…

Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats

d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754
Main Authors: Teo, Steve K, Stirling, David I, Thomas, Steve D, Khetani, Vikram D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913
cites cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913
container_end_page 754
container_issue 3
container_start_page 747
container_title Pharmacology, biochemistry and behavior
container_volume 74
creator Teo, Steve K
Stirling, David I
Thomas, Steve D
Khetani, Vikram D
description d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of d, l-MPH, d-MPH and l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg d, l-MPH and 1, 10, 50 mg/kg d-MPH or 1, 100, 500 mg/kg l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high d, l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose d, l-MPH and high dose d- and l-MPH. Responses in female were significantly different from males in d, l- and l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose d-MPH and d, l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with d- and l-MPH compared to equimolar doses of d, l-MPH. l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.
doi_str_mv 10.1016/S0091-3057(02)01073-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18645396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305702010730</els_id><sourcerecordid>18645396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</originalsourceid><addsrcrecordid>eNqFkMtOHDEQRS0EgoHwCUS9ISKLJuVXP1YoQnlJCBZJdpGsGrusMepuD3YPEn8fMzMKy6zqqnSuH4exCw7XHHjz6SdAz2sJur0C8RE4tLKGA7bgXQmat-0hW_xDTthpzo8AoETTHrMTLrSSQvEF-3NPmxSXtMLnEBMOFXlPds5V9FVCS2Ow1bxKFOuR5tXLsF7RFBzOVOHkqlBAt02lOOE0hzhSylWYSnnO79iRxyHT-X6esd9fv_y6_V7fPXz7cfv5rrZKiLnueC9VJxX2klA7KXpUoMoflly6RrVegeAahAVNZYUtLX3fFNATdq7n8ox92J27TvFpQ3k2Y8iWhgEniptseNcoLfumgHoH2hRzTuTNOoUR04vhYF61mq1W8-rMgDBbrQZK7_3-gs1yJPfW2nsswOUewGxx8AknG_IbpzRwwVXhbnYcFR3PgZLJNtBkyYVUtBsXw3-e8hdkLZOB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18645396</pqid></control><display><type>article</type><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><source>ScienceDirect Journals</source><creator>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</creator><creatorcontrib>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</creatorcontrib><description>d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of d, l-MPH, d-MPH and l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg d, l-MPH and 1, 10, 50 mg/kg d-MPH or 1, 100, 500 mg/kg l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high d, l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose d, l-MPH and high dose d- and l-MPH. Responses in female were significantly different from males in d, l- and l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose d-MPH and d, l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with d- and l-MPH compared to equimolar doses of d, l-MPH. l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(02)01073-0</identifier><identifier>PMID: 12543241</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Biological and medical sciences ; d-Methylphenidate ; Dexmethylphenidate ; Dexmethylphenidate Hydrochloride ; Drug Evaluation, Preclinical - methods ; Female ; Focalin ; Functional observational battery ; l-Methylphenidate ; Male ; Medical sciences ; Methylphenidate ; Methylphenidate - adverse effects ; Methylphenidate - chemistry ; Methylphenidate - pharmacology ; Motor Skills - drug effects ; Motor Skills - physiology ; Neurobehavioral effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Ritalin ; Rota-rod ; Stereoisomerism</subject><ispartof>Pharmacology, biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</citedby><cites>FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14501214$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12543241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teo, Steve K</creatorcontrib><creatorcontrib>Stirling, David I</creatorcontrib><creatorcontrib>Thomas, Steve D</creatorcontrib><creatorcontrib>Khetani, Vikram D</creatorcontrib><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of d, l-MPH, d-MPH and l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg d, l-MPH and 1, 10, 50 mg/kg d-MPH or 1, 100, 500 mg/kg l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high d, l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose d, l-MPH and high dose d- and l-MPH. Responses in female were significantly different from males in d, l- and l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose d-MPH and d, l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with d- and l-MPH compared to equimolar doses of d, l-MPH. l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</description><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Biological and medical sciences</subject><subject>d-Methylphenidate</subject><subject>Dexmethylphenidate</subject><subject>Dexmethylphenidate Hydrochloride</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Female</subject><subject>Focalin</subject><subject>Functional observational battery</subject><subject>l-Methylphenidate</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylphenidate</subject><subject>Methylphenidate - adverse effects</subject><subject>Methylphenidate - chemistry</subject><subject>Methylphenidate - pharmacology</subject><subject>Motor Skills - drug effects</subject><subject>Motor Skills - physiology</subject><subject>Neurobehavioral effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Ritalin</subject><subject>Rota-rod</subject><subject>Stereoisomerism</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOHDEQRS0EgoHwCUS9ISKLJuVXP1YoQnlJCBZJdpGsGrusMepuD3YPEn8fMzMKy6zqqnSuH4exCw7XHHjz6SdAz2sJur0C8RE4tLKGA7bgXQmat-0hW_xDTthpzo8AoETTHrMTLrSSQvEF-3NPmxSXtMLnEBMOFXlPds5V9FVCS2Ow1bxKFOuR5tXLsF7RFBzOVOHkqlBAt02lOOE0hzhSylWYSnnO79iRxyHT-X6esd9fv_y6_V7fPXz7cfv5rrZKiLnueC9VJxX2klA7KXpUoMoflly6RrVegeAahAVNZYUtLX3fFNATdq7n8ox92J27TvFpQ3k2Y8iWhgEniptseNcoLfumgHoH2hRzTuTNOoUR04vhYF61mq1W8-rMgDBbrQZK7_3-gs1yJPfW2nsswOUewGxx8AknG_IbpzRwwVXhbnYcFR3PgZLJNtBkyYVUtBsXw3-e8hdkLZOB</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Teo, Steve K</creator><creator>Stirling, David I</creator><creator>Thomas, Steve D</creator><creator>Khetani, Vikram D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20030201</creationdate><title>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</title><author>Teo, Steve K ; Stirling, David I ; Thomas, Steve D ; Khetani, Vikram D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Biological and medical sciences</topic><topic>d-Methylphenidate</topic><topic>Dexmethylphenidate</topic><topic>Dexmethylphenidate Hydrochloride</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Female</topic><topic>Focalin</topic><topic>Functional observational battery</topic><topic>l-Methylphenidate</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylphenidate</topic><topic>Methylphenidate - adverse effects</topic><topic>Methylphenidate - chemistry</topic><topic>Methylphenidate - pharmacology</topic><topic>Motor Skills - drug effects</topic><topic>Motor Skills - physiology</topic><topic>Neurobehavioral effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Ritalin</topic><topic>Rota-rod</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teo, Steve K</creatorcontrib><creatorcontrib>Stirling, David I</creatorcontrib><creatorcontrib>Thomas, Steve D</creatorcontrib><creatorcontrib>Khetani, Vikram D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teo, Steve K</au><au>Stirling, David I</au><au>Thomas, Steve D</au><au>Khetani, Vikram D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>74</volume><issue>3</issue><spage>747</spage><epage>754</epage><pages>747-754</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>d, l-Methylphenidate (Ritalin®) is used to treat attention deficit hyperactivity disorder (ADHD) in children. The therapeutic effect is predominantly due to the d enantiomer. Dexmethylphenidate ( d-MPH; Focalin®) was therefore developed for its better therapeutic index. The present study determined and compared the acute behavioral toxicity of d, l-MPH, d-MPH and l-MPH in rats after oral dosing. Comprehensive functional observational battery (FOB) evaluations and rota-rod tests were performed 30, 60 and 120 min after dosing. Ten rats/sex/dose were administered a single dose of vehicle, 2, 20, 100 mg/kg d, l-MPH and 1, 10, 50 mg/kg d-MPH or 1, 100, 500 mg/kg l-MPH. There was no mortality. Certain FOB evaluations were statistically significant from vehicle control at any of the time points with most occurring at 60 and 120 min in the high d, l-MPH dose. These included increases in rearing, difficulty in removal from box, arousal, click, tail-pinch and decreases in hind-limb splay distance, hind-limb grip strength and handling reactivity. Behavioral responses were also present at the mid-dose d, l-MPH and high dose d- and l-MPH. Responses in female were significantly different from males in d, l- and l-MPH groups suggesting a sex difference in sensitivity. In the rota-rod test, mean latency to remain on the rod was significantly less for males compared to control given high dose d-MPH and d, l-MPH. In females, latency times were significantly less for high doses of all three compounds. In summary, fewer significant FOBs were seen with d- and l-MPH compared to equimolar doses of d, l-MPH. l-MPH was the least potent in producing FOBs. These results were supported by rota-rod studies.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12543241</pmid><doi>10.1016/S0091-3057(02)01073-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2003-02, Vol.74 (3), p.747-754
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_18645396
source ScienceDirect Journals
subjects Animals
Behavior, Animal - drug effects
Behavior, Animal - physiology
Biological and medical sciences
d-Methylphenidate
Dexmethylphenidate
Dexmethylphenidate Hydrochloride
Drug Evaluation, Preclinical - methods
Female
Focalin
Functional observational battery
l-Methylphenidate
Male
Medical sciences
Methylphenidate
Methylphenidate - adverse effects
Methylphenidate - chemistry
Methylphenidate - pharmacology
Motor Skills - drug effects
Motor Skills - physiology
Neurobehavioral effects
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Rats
Ritalin
Rota-rod
Stereoisomerism
title Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A00%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurobehavioral%20effects%20of%20racemic%20threo-methylphenidate%20and%20its%20d%20and%20l%20enantiomers%20in%20rats&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Teo,%20Steve%20K&rft.date=2003-02-01&rft.volume=74&rft.issue=3&rft.spage=747&rft.epage=754&rft.pages=747-754&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(02)01073-0&rft_dat=%3Cproquest_cross%3E18645396%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-81934834a93ea5d329a404517b13d647f4021502c05eb13a7ebf965d3fea8d913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18645396&rft_id=info:pmid/12543241&rfr_iscdi=true